Neuraminidase inhibitors for influenza: fully evaluating benefits and harms.
No abstract available.
The Lancet. Respiratory medicine
Handel A, Ebell MH. (2015). Neuraminidase inhibitors for influenza: fully evaluating benefits and harms. The Lancet. Respiratory medicine, 3(3)
ProfessorUniversity of Georgia Continue Reading Andreas Handel